Literature DB >> 24491484

Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

R J Willcocks1, I A Arpan2, S C Forbes2, D J Lott2, C R Senesac2, E Senesac2, J Deol2, W T Triplett3, C Baligand3, M J Daniels4, H L Sweeney5, G A Walter3, K Vandenborne2.   

Abstract

Duchenne muscular dystrophy (DMD) is characterized by an increased muscle damage and progressive replacement of muscle by noncontractile tissue. Both of these pathological changes can lengthen the MRI transverse proton relaxation time (T2). The current study measured longitudinal changes in T2 and its distribution in the lower leg of 16 boys with DMD (5-13years, 15 ambulatory) and 15 healthy controls (5-13years). These muscles were chosen to allow extended longitudinal monitoring, due to their slow progression compared with proximal muscles in DMD. In the soleus muscle of boys with DMD, T2 and the percentage of pixels with an elevated T2 (⩾2SD above control mean T2) increased significantly over 1year and 2years, while the width of the T2 histogram increased over 2years. Changes in soleus T2 variables were significantly greater in 9-13years old compared with 5-8years old boys with DMD. Significant correlations between the change in all soleus T2 variables over 2years and the change in functional measures over 2years were found. MRI measurement of muscle T2 in boys with DMD is sensitive to disease progression and shows promise as a clinical outcome measure.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  30 Foot walk; Duchenne muscular dystrophy; Magnetic resonance imaging; Transverse relaxation time

Mesh:

Year:  2014        PMID: 24491484      PMCID: PMC4277599          DOI: 10.1016/j.nmd.2013.12.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

1.  Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study.

Authors:  D Cros; P Harnden; J F Pellissier; G Serratrice
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

2.  Osmotic effects on the T2 relaxation decay of in vivo muscle.

Authors:  G Gambarota; B E Cairns; C B Berde; R V Mulkern
Journal:  Magn Reson Med       Date:  2001-09       Impact factor: 4.668

3.  Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis.

Authors:  J Phoenix; D Betal; N Roberts; T R Helliwell; R H Edwards
Journal:  Muscle Nerve       Date:  1996-03       Impact factor: 3.217

4.  Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Authors:  William T Triplett; Celine Baligand; Sean C Forbes; Rebecca J Willcocks; Donovan J Lott; Soren DeVos; Jim Pollaro; William D Rooney; H Lee Sweeney; Carsten G Bönnemann; Dah-Jyuu Wang; Krista Vandenborne; Glenn A Walter
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

5.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging.

Authors:  Franklin A Marden; Anne M Connolly; Marilyn J Siegel; David A Rubin
Journal:  Skeletal Radiol       Date:  2004-10-22       Impact factor: 2.199

6.  Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.

Authors:  Isabelle Desguerre; Christo Christov; Michele Mayer; Reinhard Zeller; Henri-Marc Becane; Sylvie Bastuji-Garin; France Leturcq; Catherine Chiron; Jamel Chelly; Romain K Gherardi
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

7.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.

Authors:  Tishya A L Wren; Stefan Bluml; Linda Tseng-Ong; Vicente Gilsanz
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

8.  MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise.

Authors:  Penelope Garrood; Kieren G Hollingsworth; Michelle Eagle; Benjamin S Aribisala; Daniel Birchall; Kate Bushby; Volker Straub
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813

9.  Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging.

Authors:  Masanori Kobayashi; Akinori Nakamura; Daisuke Hasegawa; Michio Fujita; Hiromitsu Orima; Shin'ichi Takeda
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

10.  Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy.

Authors:  Y Huang; S Majumdar; H K Genant; W P Chan; K R Sharma; P Yu; M Mynhier; R G Miller
Journal:  J Magn Reson Imaging       Date:  1994 Jan-Feb       Impact factor: 4.813

View more
  57 in total

1.  Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.

Authors:  Utkarsh J Dang; Michael Ziemba; Paula R Clemens; Yetrib Hathout; Laurie S Conklin; Eric P Hoffman
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

2.  Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy.

Authors:  Abhinandan Batra; Ann Harrington; Donovan J Lott; Rebecca Willcocks; Claudia R Senesac; William McGehee; Dandan Xu; Sunita Mathur; Michael J Daniels; William D Rooney; Sean C Forbes; William Triplett; Jasjit K Deol; Ishu Arpan; Roxanne Bendixen; Richard Finkel; Erika Finanger; Gihan Tennekoon; Barry Byrne; Barry Russman; H Lee Sweeney; Glenn Walter; Krista Vandenborne
Journal:  Am J Phys Med Rehabil       Date:  2018-10       Impact factor: 2.159

3.  Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease.

Authors:  Bruce M Damon; Ke Li; Richard D Dortch; E Brian Welch; Jane H Park; Amanda K W Buck; Theodore F Towse; Mark D Does; Daniel F Gochberg; Nathan D Bryant
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

4.  MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.

Authors:  Leo H Wang; Seth D Friedman; Dennis Shaw; Lauren Snider; Chao-Jen Wong; Chris B Budech; Sandra L Poliachik; Nancy E Gove; Leann M Lewis; Amy E Campbell; Richard J F L Lemmers; Silvère M Maarel; Stephen J Tapscott; Rabi N Tawil
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

5.  Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.

Authors:  Abhinandan Batra; Ravneet S Vohra; Steve M Chrzanowski; David W Hammers; Donovan J Lott; Krista Vandenborne; Glenn A Walter; Sean C Forbes
Journal:  J Appl Physiol (1985)       Date:  2019-04-04

Review 6.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 7.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

8.  Age-dependent changes in metabolite profile and lipid saturation in dystrophic mice.

Authors:  Brittany Lee-McMullen; Stephen M Chrzanowski; Ravneet Vohra; Sean C Forbes; Krista Vandenborne; Arthur S Edison; Glenn A Walter
Journal:  NMR Biomed       Date:  2019-03-08       Impact factor: 4.044

9.  Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.

Authors:  R J Willcocks; W T Triplett; S C Forbes; H Arora; C R Senesac; D J Lott; T R Nicholson; W D Rooney; G A Walter; K Vandenborne
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

10.  Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.

Authors:  Ishu Arpan; Rebecca J Willcocks; Sean C Forbes; Richard S Finkel; Donovan J Lott; William D Rooney; William T Triplett; Claudia R Senesac; Michael J Daniels; Barry J Byrne; Erika L Finanger; Barry S Russman; Dah-Jyuu Wang; Gihan I Tennekoon; Glenn A Walter; H L Sweeney; Krista Vandenborne
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.